Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ross

Showing results (1661-1670 of 1,804) with videos related to

Pageof 181
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 2, 2026
Assessment of Bedside-Adaptable Models to Predict Molecular Sepsis Subtypes in a Resource-Limited Setting: A Multicenter Analysis from UgandaBarnabas Bakamutumaho, Julius J Lutwama, Nicholas Owor, et al.
The Journal of Urology|April 8, 2020
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate CancerWeranja Ranasinghe, Chad A Reichard, Yaw A Nyame, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2025
Utility of <sup>18</sup>F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomyEric V Li, Edward M Schaeffer, Sai Kaushik Shankar Ramesh Kumar, et al.
European Urology Oncology|August 4, 2024
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world SettingMichael S Leapman, Julian Ho, Yang Liu, et al.
NPJ Precision Oncology|March 20, 2026
Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implicationsRamin Nateghi, Aoran Sun, Hao Dang, et al.
Cancer|November 14, 2018
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centersDebasish Sundi, Jeffrey J Tosoian, Yaw A Nyame, et al.
Circulation|October 22, 2025
Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular CareJavier J Lasa, Gurpreet S Dhillon, Jonathan P Duff, et al.
Blood Cancer Journal|May 16, 2023
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy eraCristina Correia, Matthew J Maurer, Samantha J McDonough, et al.
The Lancet. Infectious Diseases|August 16, 2025
Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trialLaina D Mercer, Arlene C Seña, E Ross Colgate, et al.
Pediatrics|October 22, 2025
Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular CareJavier J Lasa, Gurpreet S Dhillon, Jonathan P Duff, et al.
Pageof 181

Showing results (1661-1670 of 1,804) with videos related to

Sort By:
Pageof 181
Medrxiv : the Preprint Server for Health Sciences|July 2, 2026
Assessment of Bedside-Adaptable Models to Predict Molecular Sepsis Subtypes in a Resource-Limited Setting: A Multicenter Analysis from UgandaBarnabas Bakamutumaho, Julius J Lutwama, Nicholas Owor, et al.
The Journal of Urology|April 8, 2020
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate CancerWeranja Ranasinghe, Chad A Reichard, Yaw A Nyame, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 10, 2025
Utility of <sup>18</sup>F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomyEric V Li, Edward M Schaeffer, Sai Kaushik Shankar Ramesh Kumar, et al.
European Urology Oncology|August 4, 2024
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world SettingMichael S Leapman, Julian Ho, Yang Liu, et al.
NPJ Precision Oncology|March 20, 2026
Prediction of molecular subtypes from histology: AI-driven analysis of prostate cancer morphological patterns and therapeutic implicationsRamin Nateghi, Aoran Sun, Hao Dang, et al.
Cancer|November 14, 2018
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centersDebasish Sundi, Jeffrey J Tosoian, Yaw A Nyame, et al.
Circulation|October 22, 2025
Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular CareJavier J Lasa, Gurpreet S Dhillon, Jonathan P Duff, et al.
Blood Cancer Journal|May 16, 2023
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy eraCristina Correia, Matthew J Maurer, Samantha J McDonough, et al.
The Lancet. Infectious Diseases|August 16, 2025
Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trialLaina D Mercer, Arlene C Seña, E Ross Colgate, et al.
Pediatrics|October 22, 2025
Part 8: Pediatric Advanced Life Support: 2025 American Heart Association and American Academy of Pediatrics Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular CareJavier J Lasa, Gurpreet S Dhillon, Jonathan P Duff, et al.
Pageof 181